Correlation between gene mutation status and selected clinical features
Uterine Carcinosarcoma (Primary solid tumor)
16 April 2014 | analyses__2014_04_16
Maintainer Information
Citation Information
doi:10.7908/C10Z7206
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between gene mutation status and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C10Z7206
Overview
Introduction

This pipeline computes the correlation between significantly recurrent gene mutations and selected clinical features.

Summary

Testing the association between mutation status of 9 genes and 2 clinical features across 57 patients, no significant finding detected with Q value < 0.25.

- No gene mutations related to clinical features.

Results
Overview of the results

Table 1. Get Full Table Overview of the association between mutation status of 9 genes and 2 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, no significant finding detected.

|  | Clinical Features | Time to Death | AGE
| nMutated (%) | nWild-Type | logrank test | t-test
FBXW7 | 22 (39%) | 35 | 0.567 (1.00) | 0.572 (1.00)
KRAS | 7 (12%) | 50 | 0.434 (1.00) | 0.782 (1.00)
TP53 | 51 (89%) | 6 | 0.545 (1.00) | 0.0428 (0.771)
PIK3CA | 20 (35%) | 37 | 0.183 (1.00) | 0.211 (1.00)
PPP2R1A | 16 (28%) | 41 | 0.777 (1.00) | 0.8 (1.00)
PTEN | 11 (19%) | 46 | 0.239 (1.00) | 0.618 (1.00)
PIK3R1 | 6 (11%) | 51 | 0.705 (1.00) | 0.079 (1.00)
ZBTB7B | 6 (11%) | 51 | 0.0731 (1.00) | 0.444 (1.00)
RB1 | 6 (11%) | 51 | 0.23 (1.00) | 0.417 (1.00)

Methods & Data
Input

- Mutation data file = transformed.cor.cli.txt

- Clinical data file = UCS-TP.merged_data.txt

- Number of patients = 57

- Number of significantly mutated genes = 9

- Number of selected clinical features = 2

- Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Student's t-test analysis

For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

- Analysis Results (MD5 checksum)

- Auxiliary Data (MD5 checksum)

- MAGE-TAB File (MD5 checksum)

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)
Copyright © 2014 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle